 |
Home
 COPD: Expanding the Key Role of the
Pharmacist
To obtain continuing
education credit for this program, participants must complete the
online program evaluation form by July 31, 2008.
Note: You will need your Pharmacist.com username and
password to register for the webinar and to take the test for CE
credit. If you do not have a Pharmacist.com username and
password, create
one now.
Chronic obstructive pulmonary disease (COPD) has been called
“the largest uncontrolled epidemic of disease in the United States
today.” Although COPD cannot be cured, recent advances in
our understanding of the disease process—coupled with the
introduction of effective new therapies—provide substantial
opportunity for improved patient survival and quality of life.
Pharmacists are in a key position to contribute to many important
aspects of disease management. By participating in this webinar,
pharmacists will gain the knowledge and tools they need to help patients
lead a life as free from symptoms as possible.
Learning Objectives
After participating in this webinar, pharmacists will be able to:
-
Review the epidemiology, etiology, and pathophysiology of chronic
obstructive pulmonary disease (COPD).
-
Describe the diagnosis, classification, and risk factors for
COPD.
-
Discuss the current strategies/guidelines for the management of
COPD including the nondrug and drug therapy options.
-
Outline the patient criteria for specific product selection and
benefits of therapy.
-
Highlight how the pharmacist in various practice settings can play
a key role in COPD management and education.
Speakers
Karen J. Tietze, PharmD
Professor of Clinical Pharmacy
University of the Sciences in Philadelphia
Philadelphia College of Pharmacy
Philadelphia, Pennsylvania
Dennis M. Williams, PharmD
Associate Professor
University of North Carolina
School of Pharmacy
Chapel Hill, North Carolina
Financial Disclosures
Karen J. Tietze, PharmD, declares no conflicts of
interest or financial interests in any product or service mentioned in
this program, including grants, employment, gifts, stock holdings, and
honoraria.
Dennis M. Williams, PharmD, has served on the
speakers bureaus for AstraZeneca and Boehringer Ingelheim.
APhA’s editorial staff declares no conflicts
of interest or financial interests in any product or service mentioned
in this program, including grants, employment, gifts, stock holdings,
and honoraria.
CE Credit
 The American Pharmacists Association
is accredited by the Accreditation Council for Pharmacy Education as a
provider of continuing pharmacy education. This program, COPD:
Expanding the Key Role of the Pharmacist, ACPE #202-000-08-108-L04-P, is
approved for 2 hours of continuing education credit (0.2 CEUs).
There is no fee to participate in this activity.
To obtain continuing education credit for this program, participants
must pre-register online (limited to 200 seats), participate in the
entire program, and complete the online program evaluation form by
July 31, 2008. A Statement of Credit will be
automatically generated upon achieving these requirements.
Participants can obtain continuing education credit for only one of the
five offerings of this webinar.
If you attended this symposium, COPD: Expanding the Key
Role of the Pharmacist (ACPE #202-000-08-108-L04-P), on March 16, 2008
at the APhA Annual Meeting in San Diego, California and received CE
credit, you are not eligible for additional credit.
Initial Release Date: March 16, 2008
This webinar was developed by the American Pharmacists Association
and supported through an educational grant from Boehringer Ingelheim and
Pfizer.
  
|
